Column GROUP Gp, L.P. is 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM). They have made 6 open-market trades across 2 companies since 2019, most recently 2023-01-30.
CIK 0001614627
6 open-market purchases totalling $15.4M since 2019, never a sale. Across 6 scored buys the stock is up 76.0% at ninety days, and 72.7 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 67% | 67% |
| Avg Move | +12.6% | +51.1% | +76.0% |
| Alpha | +13.7% | +51.2% | +72.7% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NGM | BUY | 2023-01-30 | 2023-02-01 | $5.00 | $38K | -9.6% | -20.7% | -32.2% |
| NGM | BUY | 2022-12-12 | 2022-12-14 | $4.98 | $1K | -16.1% | -0.6% | -26.5% |
| NGM | BUY | 2022-05-31 | 2022-06-02 | $13.46 | $2.1M | -8.8% | +1.7% | +2.5% |
| NGM | BUY | 2022-05-09 | 2022-05-11 | $10.95 | $1.3M | +28.7% | +20.8% | +52.1% |
| NGM | BUY | 2019-11-11 | 2019-11-13 | $12.00 | $180 | +21.5% | +45.0% | +26.1% |
| CNST | BUY | 2019-10-03 | 2019-10-07 | $8.50 | $12.0M | +59.9% | +260.3% | +434.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.